220 related articles for article (PubMed ID: 32361531)
1. Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics.
Napoli C; Benincasa G; Donatelli F; Ambrosio G
Am Heart J; 2020 Jun; 224():113-128. PubMed ID: 32361531
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure.
Pepin ME; Drakos S; Ha CM; Tristani-Firouzi M; Selzman CH; Fang JC; Wende AR; Wever-Pinzon O
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H674-H684. PubMed ID: 31298559
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs.
Mansueto G; Benincasa G; Della Mura N; Nicoletti GF; Napoli C
J Clin Pathol; 2020 Sep; 73(9):535-543. PubMed ID: 32616540
[TBL] [Abstract][Full Text] [Related]
4. Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.
Cypen J; Ahmad T; Testani JM; DeVore AD
Curr Heart Fail Rep; 2017 Oct; 14(5):434-443. PubMed ID: 28803400
[TBL] [Abstract][Full Text] [Related]
5. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
[TBL] [Abstract][Full Text] [Related]
7. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
8. Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes.
Glezeva N; Moran B; Collier P; Moravec CS; Phelan D; Donnellan E; Russell-Hallinan A; O'Connor DP; Gallagher WM; Gallagher J; McDonald K; Ledwidge M; Baugh J; Das S; Watson CJ
Circ Heart Fail; 2019 Mar; 12(3):e005765. PubMed ID: 30798618
[TBL] [Abstract][Full Text] [Related]
9. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
10. Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides.
Tsutamoto T; Sakai H; Yamamoto T; Nakagawa Y
Int Heart J; 2020 Jan; 61(1):77-82. PubMed ID: 31956150
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptide-guided heart failure management.
Troughton R; Michael Felker G; Januzzi JL
Eur Heart J; 2014 Jan; 35(1):16-24. PubMed ID: 24216390
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure.
Pepin ME; Ha CM; Crossman DK; Litovsky SH; Varambally S; Barchue JP; Pamboukian SV; Diakos NA; Drakos SG; Pogwizd SM; Wende AR
Lab Invest; 2019 Mar; 99(3):371-386. PubMed ID: 30089854
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
15. Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients.
Napoli C; Benincasa G; Schiano C; Salvatore M
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):239-247. PubMed ID: 31665258
[TBL] [Abstract][Full Text] [Related]
16. Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
Hirakawa K; Yamamuro M; Uemura T; Takashio S; Kaikita K; Utsunomiya D; Nakayama M; Yamamoto E; Yamashita Y; Hokimoto S; Tsujita K
Int J Cardiol; 2017 Feb; 228():881-885. PubMed ID: 27889555
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide levels in obese patients with advanced heart failure.
Horwich TB; Hamilton MA; Fonarow GC
J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
[TBL] [Abstract][Full Text] [Related]
18. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
[TBL] [Abstract][Full Text] [Related]
19. ST2 elevation in heart failure, predictive of a high early mortality.
Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation in heart failure: part II DNA and chromatin.
DiSalvo TG
Cardiol Rev; 2015; 23(6):269-81. PubMed ID: 26135900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
